BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23792527)

  • 1. Waiting time, not donor-risk-index, is a major determinant for beneficial outcome after liver transplantation in high-MELD patients.
    Rauchfuss F; Zidan A; Scheuerlein H; Dittmar Y; Bauschke A; Settmacher U
    Ann Transplant; 2013 May; 18():243-7. PubMed ID: 23792527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Nekrasov V; Matsuoka L; Kaur N; Pita A; Whang G; Cao S; Groshen S; Alexopoulos S
    Transplantation; 2017 Oct; 101(10):2360-2367. PubMed ID: 28319564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthotopic liver transplantation in critically ill cirrhotic patients with multi-organ failure: a single-center experience.
    Umgelter A; Lange K; Kornberg A; Büchler P; Friess H; Schmid RM
    Transplant Proc; 2011 Dec; 43(10):3762-8. PubMed ID: 22172843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.
    Pestana RC; Baracat EI; Massarollo PC; Pereira LA; Szutan LA
    Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developments in pediatric liver transplantation since implementation of the new allocation rules in Eurotransplant.
    Herden U; Grabhorn E; Briem-Richter A; Ganschow R; Nashan B; Fischer L
    Clin Transplant; 2014 Sep; 28(9):1061-8. PubMed ID: 25040668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the MELD allocation after its implementation in liver transplantation.
    Benckert C; Quante M; Thelen A; Bartels M; Laudi S; Berg T; Kaisers U; Jonas S
    Scand J Gastroenterol; 2011 Jul; 46(7-8):941-8. PubMed ID: 21443420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept.
    Weismüller TJ; Fikatas P; Schmidt J; Barreiros AP; Otto G; Beckebaum S; Paul A; Scherer MN; Schmidt HH; Schlitt HJ; Neuhaus P; Klempnauer J; Pratschke J; Manns MP; Strassburg CP
    Transpl Int; 2011 Jan; 24(1):91-9. PubMed ID: 20819196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
    Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of split liver transplantation for 2 adults in the model of end-stage liver disease era.
    Lee WC; Chan KM; Chou HS; Wu TJ; Lee CF; Soong RS; Wu TH; Lee CS
    Ann Surg; 2013 Aug; 258(2):306-11. PubMed ID: 23108123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living donor liver transplantation in adults in the MELD era in Germany--a multi-center retrospective analysis.
    Settmacher U; Götz M; Rahmel A; Bärthel E; Schlitt H; Puhl G; Broering D; Lehner F; Fischer L; Paul A; Schmidt J; Nadalin S; Obed A; Heise M
    Transpl Int; 2011 Sep; 24(9):904-11. PubMed ID: 21668530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
    Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
    Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.
    Agopian VG; Petrowsky H; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Holt C; Harlander-Locke M; Hong JC; Rana AR; Venick R; McDiarmid SV; Goldstein LI; Durazo F; Saab S; Han S; Xia V; Hiatt JR; Busuttil RW
    Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing the donor pool reduces the severity of liver disease: lessons learned from São Paulo, Brazil.
    Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2286-8. PubMed ID: 23026575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.
    Dutkowski P; Oberkofler CE; Slankamenac K; Puhan MA; Schadde E; Müllhaupt B; Geier A; Clavien PA
    Ann Surg; 2011 Nov; 254(5):745-53; discussion 753. PubMed ID: 22042468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of model for end-stage liver disease score on long-term survival following liver transplantation for hepatocellular carcinoma.
    Roma J; Balbi E; Pacheco-Moreira L; Zyngier I; Araujo A; Agoglia L; Steinbruck K; Velaverde LG; Martinho JM
    Transplant Proc; 2012 Oct; 44(8):2423-7. PubMed ID: 23026611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality.
    Schaubel DE; Sima CS; Goodrich NP; Feng S; Merion RM
    Am J Transplant; 2008 Feb; 8(2):419-25. PubMed ID: 18190658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.